vaxelis
mcm vaccine b.v. - davica toxoid, tetanus toxoid, bordetella oslovskemu kašlju antigenov: oslovskemu kašlju toxoid, nitastih haemagglutinin, pertactin, fimbriae vrste 2 in 3, hepatitis b surface antigen, proizvedene v kvas celice, poliovirus (inaktivirano): tip 1 (mahoney), tip 2 (mef-1), tip 3 (saukett), ki v chicagu celic/ haemophilus influenzae tipa b polysaccharide (polyribosylribitol fosfat) konjugiran na meningococcal beljakovin. - meningitis, haemophilus; poliomyelitis; tetanus; diphtheria; whooping cough; hepatitis b - cepiva - vaxelis (dtap-hb-ipv-hib) je indicirano za osnovno in obnovitveno cepljenje pri dojenčkih in malčkih od starosti 6 tednov, proti davici, tetanus, oslovski kašelj, hepatitis b, otroški ohromelosti in invazivnih bolezni, ki povzroča haemophilus influenzae tipa b (hib). uporaba zdravila vaxelis mora biti v skladu z uradnimi priporočili.
monopost 50 mikrogramov/ml kapljice za oko, raztopina
laboratoires thea - latanoprost - kapljice za oko, raztopina - latanoprost 50 µg / 1 ml - latanoprost
regaine za ženske 50 mg/g dermalna pena
mcneil products limited, foundation park, roxborough way - minoksidil - dermalna pena - minoksidil 50 mg / 1 g - minoksidil
libmeldy
orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - druga zdravila na živčnem sistemu - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still have the ability to walk independently and before the onset of cognitive decline.
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - multiple myeloma - antineoplastična sredstva - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
pylclari
curium pet france - piflufolastat (18f) - prostatične neoplazme - diagnostični radiofarmacevtiki - to zdravilo je samo za diagnostično uporabo. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
citafort 15 mg orodisperzibilne tablete
lek d.d. - escitalopram - orodisperzibilna tableta - escitalopram 15 mg / 1 tableta - escitalopram
menadex 12,5 mg zrnca za peroralno raztopino
menarini international o.l.s.a. - deksketoprofen - zrnca za peroralno raztopino - deksketoprofen 12,5 mg / 1 vrečica - deksketoprofen
bekunis zdravilni čaj
bitrade d.o.o. - list sene; plod ostrolistne sene; plod ozkolistne sene - zdravilni čaj - list sene 25 g / 100 g plod ostrolistne sene25 g / 100 g plod ozkolistne sene50 g / 100 g; plod ostrolistne sene 25 g / 100 g plod ozkolistne sene50 g / 100 g; plod ozkolistne sene 50 g / 100 g - kontaktna odvajala
verolax senna 15 mg filmsko obložene tablete
krka, d.d., novo mesto - suhi ekstrakt lista sene, standardizirani - filmsko obložena tableta - suhi ekstrakt lista sene, standardizirani 33,5 mg / 1 tableta - kontaktna odvajala